U
Udo Losert
Researcher at Medical University of Vienna
Publications - 140
Citations - 3469
Udo Losert is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Artificial heart & Hypothermia. The author has an hindex of 31, co-authored 140 publications receiving 3367 citations. Previous affiliations of Udo Losert include University of Vienna.
Papers
More filters
Journal ArticleDOI
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty.
Michael Rolf Mueller,Andreas Salat,Petra Stangl,Marco Murabito,Sad Pulaki,Dagmar Boehm,Renate Koppensteiner,Erdem Ergun,Martina Mittlboeck,Wolfgang Schreiner,Udo Losert,Ernst Wolner +11 more
TL;DR: Comparison of the CWBA-results with clinical parameters revealed that reocclusions at the site of angioplasty occurred exclusively in male patients for which CWBA failed to prove an inhibition of aggregation upon both agonists, ADP and collagen, and for these patients the risk of complication is at least 87% higher.
Journal ArticleDOI
l-Arginine Treatment Alters the Kinetics of Nitric Oxide and Superoxide Release and Reduces Ischemia/Reperfusion Injury in Skeletal Muscle
Igor Huk,Joseph Nanobashvili,Christoph Neumayer,Andreas Punz,Markus Mueller,Kaweh Afkhampour,Martina Mittlboeck,Udo Losert,Peter Polterauer,Erich Roth,Stephen Patton,Tadeusz Malinski +11 more
TL;DR: L-Arginine treatment decreased superoxide generation by cNOS while increasing NO accumulation, leading to protection from constriction, and reduction of edema after reperfusion in animals treated with L-arginine.
Journal ArticleDOI
Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells.
Reinhard Gruber,Barbara Kandler,Phillip Holzmann,Margit Vögele-Kadletz,Udo Losert,Michael B. Fischer,Georg Watzek +6 more
TL;DR: It is suggested that mesenchymal progenitor cells can support the process of blood vessel formation, which may be relevant during granulation tissue formation at defect sites.
Journal ArticleDOI
Reduction of infarct size induced by pressure-controlled intermittent coronary sinus occlusion.
Werner Mohl,Dietmar Glogar,Harald Mayr,Udo Losert,Heinz Sochor,Othmar Pachinger,F. Kaindl,Ernst Wolner +7 more
TL;DR: Intermittent occlusion may be an effective treatment for evolving MI and appears to have great clinical potential, used alone or combined with other therapies.
Journal ArticleDOI
Chitosan-thioglycolic acid conjugate: a new scaffold material for tissue engineering?
TL;DR: Chitosan-TGA is a promising candidate as scaffold material in tissue engineering because of the improved in situ gelling and the influence of the thiol groups on the viability of L-929 mouse fibroblasts.